Fierce Biotech February 23, 2024
Researchers at the Washington University in St. Louis and Lund University in Sweden have taken a step closer toward developing a blood test that could be used during an annual doctor’s office visit to help catch cases of Alzheimer’s disease.
Making a simple and accurate blood test available to primary care providers would upend traditional diagnostic methods, where invasive spinal tap procedures or brain scans typically only come after a patient has begun demonstrating cognitive decline.
The researchers—some of whom previously worked with the Washington University’s spinout C2N Diagnostics, a former Fierce 15 winner and developer of the PrecivityAD blood tests for Alzheimer’s—say this new assay is capable of performing on par with PET scans and analyses of cerebrospinal...